About
Pfizer Ventures, the corporate venture capital arm of Pfizer Inc., was founded in 2004. It invests globally in innovative biopharmaceutical companies that are advancing breakthrough medicines and technologies with the potential to enhance Pfizer's pipeline and shape the future of the industry. Pfizer Ventures focuses on areas of strategic interest to Pfizer, including oncology, inflammation & immunology, cardiovascular, metabolic/obesity, and vaccines, as well as platform technology companies. They invest across all stages of development, with a strong emphasis on early-stage opportunities, and typically make initial investments ranging from $5–20 million. While primarily U.S. focused, international investments may represent up to 20% of the portfolio.
Portfolio · 1
Investment activity
Portfolio by sector
Q&A
- What is Pfizer Ventures' primary investment focus?
- Pfizer Ventures primarily focuses on the Health Tech & Life Sciences sector, with all of its portfolio companies and investment rounds concentrated in this area.
- Can you name some of Pfizer Ventures' portfolio companies?
- Pfizer Ventures' portfolio includes DenovAI Biotech, which focuses on dynamic protein design, and Metabomed, which develops target-inhibiting anticancer drugs.
- What was Pfizer Ventures' most recent investment?
- Pfizer Ventures participated in a Seed round for DenovAI Biotech in February 2023, which raised $4M.
- What is the typical investment range for Pfizer Ventures?
- Pfizer Ventures typically invests between $1M and $18M.
- What kind of investment stages does Pfizer Ventures participate in?
- Pfizer Ventures has participated in Pre-Seed, A Round, and Seed stage investments.
- When was Pfizer Ventures founded?
- Pfizer Ventures was founded in 2019.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Legal name | Pfizer Venture Investments LLC (PVI) |
|---|---|
| Founded | 2004 |